| New Adjuvant Treatments For Breast Cancer Prove Cost-effective
Science Daily New adjuvant treatments for breast cancer are cost-effective at improving survival, according to two new studies. Published inthe journal CANCER, the two studies looked at the cost-effectiveness of different drugs for the management of adjuvant therapies for early breast cancer. .
Substance In Tree Bark Could Lead To New Lung-Cancer Treatment
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.
The compound, called beta-lapachone, has shown promising anti-cancer properties and is currently being used in a clinical trial to examine its effectiveness against pancreatic cancer in humans. Until now, however, researchers didn't know the mechanism of how the compound killed cancer cells.
Dr. David Boothman, a professor in the Harold C. Simmons Comprehensive Cancer Center and senior author of a study appearing online in the Proceedings of the National Academy of Sciences, has been researching the compound and how it causes cell death in cancerous cells for 15 years.
Prostate cancer treatment cuts hot flashes
ROCHESTER, Minn., June 4: A U.S. study finds use of low doses of an epileptic seizure medication can significantly reduce the occurrence of hot flashes in prostate cancer patients.The North Central Cancer Treatment Group researchers based at the Mayo Clinic found use of the drug gabapentin that's also used to treat nerve pain caused by shingles substantially reduces hot flashes in men undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.The investigators found gabapentin cut the frequency and intensity of hot flashes up to 46 percent in men receiving androgen deprivation therapy."To my knowledge, this is the first non-hormonal treatment of hot flashes in men, where results from a placebo-controlled trial are positive enough to support that a non-hormonal medication can be used to help some of our patients," lead investigator Dr.
|
